New data shows Wuhan COVID-19 fatality rate 1.4 percent, lower than other countries

It is now abundantly clear that COVID-19 is not "just the flu" as Italy grapples to contain the virus. The country has taken surpassed the death toll of China since it recorded 5,476 deaths with a fatality rate of 8.3 percent. China has first shown a fatality rate of 2 to 3.4 percent, but a new study shows that the rate is lower than previously known.

The study, published in the journal Nature Medicine, says that the death rate in Wuhan City, where the coronavirus emerged, is around 1.4 percent. The new estimate is based on the latest available data on Feb. 29.

The paper focused on Wuhan City, the epicenter of the outbreak, three months ago. The novel coronavirus first emerged in a wet market in Wuhan City in Hubei Province, China. Since first reported in December 2019, cases have spread across China and now, throughout the globe.

"A key public health priority during the emergence of a novel pathogen is estimating clinical severity," the researchers wrote on the paper.

Novel Coronavirus SARS-CoV-2 Colorized scanning electron micrograph of an apoptotic cell (green) heavily infected with SARS-COV-2 virus particles (purple), isolated from a patient sample. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Credit: NIAID
Novel Coronavirus SARS-CoV-2 Colorized scanning electron micrograph of an apoptotic cell (green) heavily infected with SARS-COV-2 virus particles (purple), isolated from a patient sample. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Credit: NIAID

The new figure

The new data shows a significant decrease in the previously known 2 to 3 percent fatality rate. But experts warn that despite the low fatality rate of the coronavirus, it can infect many people, with a majority of the population infected.

The seasonal flu is a human virus, which infects most people now and then. This means that most people have some sort of immunity for the illness. In comparison, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an animal virus that has jumped across to humans. Therefore most people on the planet do not have immunity against the disease.

This explains why most people who are old, frail, and sick with underlying medical conditions are at a higher risk of experiencing severe COVID-19. Their immune systems are already compromised, making it hard for the body to get rid of the deadly virus.

The new death rate raises hopes that the worse complications of the novel coronavirus will be uncommon.

To compare, Italy, the Philippines, and Malaysia have high fatality rates of 8 percent. Malaysia and the Philippines have just started to report local transmissions, making it still too early to look at their death rates.

Still higher than flu

The death rate of coronavirus is much higher than influenza, commonly known as the flu, which infects millions of people each year but only has a 0.1 percent fatality rate in the United States. Influenza is a highly infectious viral illness caused by influenza A or B viruses. It affects the nose and throat and may also affect the lungs.

To arrive at their findings, the authors calculated the estimates based on the latest cases in Wuhan, including 48,557 confirmed patients and 2,169 deaths. The authors also noted that the older a person is, the higher the fatality risk.

People who are over 60 years old had a death risk of 2.6 percent, making the older adults age group five times more likely to die than those with symptoms between the ages of 30 and 59 years old, with a death risk of 0.5 percent. People who are below 30 years old had a fatality risk of 0.3 percent.

More infections

Across the globe, there are now 331,373 confirmed cases of the coronavirus disease (COVID-19), with 140,450 deaths, as reported by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). Many countries and healthcare systems are struggling due to the lack of testing kits, making disease confirmation harder and longer.

Since the COVID-19 outbreak began to pick up steam in Wuhan, health experts have since clamored to understand the nature of the virus. They believe that with the number of infections, many are still undetected.

For instance, in most countries, testing kits are allotted for those with symptoms of the disease. Some countries fail to test other people who may be exposed to the virus since they do not manifest symptoms severe enough to seek medical attention. Further, millions regard COVID-19 as a simple cold or flu, enhancing the spread of the virus.

If more people go undetected and untested, many people are at a high risk of contracting the virus without them knowing it.

"Estimation of true case numbers—necessary to determine the severity per case—is challenging in the setting of an overwhelmed healthcare system that cannot ascertain cases effectively," the authors wrote in the paper.

"Therefore...our approach has been to use a range of publicly available and recently published data sources...to build a picture of the full number of cases and deaths by age group," they added.

In summing up, the researchers say, "Our inferences were based on a variety of sources, and have a number of caveats, but considering the totality of the findings, they nevertheless indicate that COVID-19 transmission is difficult to control. With a basic reproductive number of around two, we might expect at least half of the population to be infected, even with aggressive use of community mitigation measures. Perhaps the most important target of mitigation measures would be to 'flatten out' the epidemic curve, reducing the peak demand on healthcare services and buying time for better treatment pathways to be developed. In due course, but almost certainly after the first global wave of infections, vaccines may also be available to protect against infection or severe disease."

Sources:
Journal reference:
Angela Betsaida B. Laguipo

Written by

Angela Betsaida B. Laguipo

Angela is a nurse by profession and a writer by heart. She graduated with honors (Cum Laude) for her Bachelor of Nursing degree at the University of Baguio, Philippines. She is currently completing her Master's Degree where she specialized in Maternal and Child Nursing and worked as a clinical instructor and educator in the School of Nursing at the University of Baguio.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Laguipo, Angela. (2020, March 22). New data shows Wuhan COVID-19 fatality rate 1.4 percent, lower than other countries. News-Medical. Retrieved on December 28, 2024 from https://www.news-medical.net/news/20200322/New-data-shows-Wuhan-COVID-19-fatality-rate-14-percent-lower-than-other-countries.aspx.

  • MLA

    Laguipo, Angela. "New data shows Wuhan COVID-19 fatality rate 1.4 percent, lower than other countries". News-Medical. 28 December 2024. <https://www.news-medical.net/news/20200322/New-data-shows-Wuhan-COVID-19-fatality-rate-14-percent-lower-than-other-countries.aspx>.

  • Chicago

    Laguipo, Angela. "New data shows Wuhan COVID-19 fatality rate 1.4 percent, lower than other countries". News-Medical. https://www.news-medical.net/news/20200322/New-data-shows-Wuhan-COVID-19-fatality-rate-14-percent-lower-than-other-countries.aspx. (accessed December 28, 2024).

  • Harvard

    Laguipo, Angela. 2020. New data shows Wuhan COVID-19 fatality rate 1.4 percent, lower than other countries. News-Medical, viewed 28 December 2024, https://www.news-medical.net/news/20200322/New-data-shows-Wuhan-COVID-19-fatality-rate-14-percent-lower-than-other-countries.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study finds nirmatrelvir-ritonavir reduces severe COVID-19 and long COVID risks in high-risk patients